2021 - Managing GMP Compliance and Phase Appropriate GMP Considerations for Virtual Companies
Date2021-03-01 - 2021-03-02
Deadline2021-02-19
VenueVirtual Seminar, USA - United States
KeywordsPhase appropriate gmp; Fda gmp workshop; FDA GMP Expectations
Topics/Call fo Papers
Understand the fundamentals of GMP for the United States
Understand how to determine what GMP-governed operations you are performing internally versus what you are outsourcing
Understand a method to structure your quality management system and decide which procedures you need now versus which ones can wait
Understand best practices for vendor management
Learn how to apply GMP concepts to Phase 1, 2 and 3 investigational drugs
Learn the differences between an FDA GMP inspection, a Pre-Approval Inspection and a Pre-License Inspection and where to obtain guidance for each
Understand basic principles of FDA inspection authority, what to expect if FDA inspects your virtual firm, and how to manage the presence of FDA personnel on site
Understand how to determine what GMP-governed operations you are performing internally versus what you are outsourcing
Understand a method to structure your quality management system and decide which procedures you need now versus which ones can wait
Understand best practices for vendor management
Learn how to apply GMP concepts to Phase 1, 2 and 3 investigational drugs
Learn the differences between an FDA GMP inspection, a Pre-Approval Inspection and a Pre-License Inspection and where to obtain guidance for each
Understand basic principles of FDA inspection authority, what to expect if FDA inspects your virtual firm, and how to manage the presence of FDA personnel on site
Other CFPs
- Regulatory Compliance for Dietary Supplements in the US, EU and Canada
- Medical Device Single Audit Program [MDSAP] Implementation & Participating Country Regulatory Processes: U.S., Canada, Brazil, Australia and Japan
- Coping with FDA Import Delays, including COVID-19, Expedited Imports and Detentions
- Navigating the Medical Device Post-Market Maze and Challenges during COVID-19 Pandemic - Learn what FDA is really thinking on regulation and guidance documents
- First International Conference on ICT for Health, Accessibility and Wellbeing (IHAW 2021)
Last modified: 2021-02-06 21:22:06